https://www.selleckchem.com/pr....oducts/pf-06826647.h
249). Serum P1NP and Alkaline Phosphatase (ALP) decreased significantly 82ng/mL vs 55ng/mL, p=0.023 and 119 IU/L vs 84 IU/L, p=0.020, respectively. In denosumab-treated patients pain scores improved leading to pain medication reduction. This correlated with lesional uptake whilst healthy bone activity did not change. BTMs and FTV correlated positively, P1NP r=0.730; p0.001 and ALP r=0.406; p=0.006, as dis change in BTMs and FTV P1NP (p=0.032) and ALP (p=0.024). FAS strongly correlated with treatment-induced decrease in ALP (p=0.
Like
Comment
Share
